Buchanan W, Kean C, Rainsford K, Kean W
Inflammopharmacology. 2023; 32(1):61-71.
PMID: 37535211
DOI: 10.1007/s10787-023-01303-z.
Stanway J, Walker D
Rheumatol Adv Pract. 2022; 6(1):rkac015.
PMID: 35265790
PMC: 8902173.
DOI: 10.1093/rap/rkac015.
Kerrigan S, McInnes I
Nat Rev Rheumatol. 2020; 16(3):179-183.
PMID: 32066941
DOI: 10.1038/s41584-020-0375-7.
Kingsmore K, Grammer A, Lipsky P
Nat Rev Rheumatol. 2019; 16(1):32-52.
PMID: 31831878
DOI: 10.1038/s41584-019-0337-0.
Worboys M, Toon E
Hist Philos Life Sci. 2019; 41(4):54.
PMID: 31701313
PMC: 6838030.
DOI: 10.1007/s40656-019-0269-7.
Gold Therapy in Rheumatoid Arthritis.
Br Med J. 2010; 1(5290):1464-5.
PMID: 20789424
PMC: 1958584.
Rheumatoid arthritis a review of recent literature.
Boland E
Calif Med. 2010; 67(5):315-24.
PMID: 20269329
PMC: 1643171.
The heart in rheumatoid arthritis.
Rogen A
Br Med J. 2010; 1(4489):87.
PMID: 20244675
PMC: 2052400.
DOI: 10.1136/bmj.1.4489.87.
CONTROLLED EVALUATION OF GOLD THERAPY IN RHEUMATOID ARTHRITIS.
WAINE H, Baker F, METTIER S
Calif Med. 1947; 66(5):295-6.
PMID: 18731216
PMC: 1642920.
Complications of gold therapy and their management.
Kuzell W
Calif Med. 1949; 71(2):140-3.
PMID: 18134898
PMC: 1520135.
Some concepts of rheumatic disease.
Kellgren J
Br Med J. 1952; 1(4769):1152-7.
PMID: 14925406
PMC: 2023637.
DOI: 10.1136/bmj.1.4769.1152.
Late results of gold treatment in rheumatoid arthritis.
Egelius N, Havermark N, NYSTROM G
Ann Rheum Dis. 1952; 11(1):17-22.
PMID: 14915428
PMC: 1030568.
DOI: 10.1136/ard.11.1.17.
[Drug therapy of rheumatoid arthritis].
Arndt U, Rittmeister M, Moller B
Orthopade. 2003; 32(12):1095-103.
PMID: 14655006
DOI: 10.1007/s00132-003-0560-9.
Studies with radioactive gold.
Lawrence J
Ann Rheum Dis. 1961; 20:341-52.
PMID: 14462996
PMC: 1007233.
DOI: 10.1136/ard.20.4.341.
GOLD therapy in rheumatoid arthritis. Report of a multicentre control trial.
Ann Rheum Dis. 1960; 19:95-119.
PMID: 13856636
PMC: 1007132.
Factors in gold dosage and toxicity in rheumatoid arthritis.
Lawrence J
Ann Rheum Dis. 1953; 12(2):129-35.
PMID: 13058282
PMC: 1030469.
DOI: 10.1136/ard.12.2.129.
Observations on gold therapy in rheumatoid arthritis.
BROWN R, CURRIE J
Br Med J. 1953; 1(4816):916-8.
PMID: 13032554
PMC: 2016316.
DOI: 10.1136/bmj.1.4816.916.
A clinical and economic review of disease-modifying antirheumatic drugs.
Gabriel S, Coyle D, Moreland L
Pharmacoeconomics. 2001; 19(7):715-28.
PMID: 11548909
DOI: 10.2165/00019053-200119070-00002.
A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.
Bendix G, Bjelle A
Ann Rheum Dis. 1996; 55(3):169-76.
PMID: 8712879
PMC: 1010123.
DOI: 10.1136/ard.55.3.169.
Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.
Ann Rheum Dis. 1982; 41 Suppl 1:1-60.
PMID: 7065738
PMC: 1030282.
DOI: 10.1136/ard.41.suppl_1.1-a.
